Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-10-04
2005-10-04
Chang, Celia (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S300000, C546S113000, C546S187000
Reexamination Certificate
active
06951871
ABSTRACT:
Disclosed are novel compounds of the formulawherein M1is CH or N and M2is C(R3) or N; R1is optionally substituted indolyl or an aza derivative thereof; R2is optionally substituted aryl or heteroaryl; and the remaining variables are as defined in the specification.Also disclosed are pharmaceutical compositions comprising the compounds of formula I.Also disclosed are methods of treating various diseases or conditions, such as, for example, allergy, allergy-induced airway responses, and congestion (e.g., nasal congestion) using the compounds of Formula I.Also disclosed are methods of treating various diseases or conditions, such as, for example, allergy, allergy-induced airway responses, and congestion (e.g., nasal congestion) using the compounds of formula I in combination with a H1receptor antagonist.
REFERENCES:
patent: 5217986 (1993-06-01), Pomponi et al.
patent: 5352707 (1994-10-01), Pompni et al.
patent: 5846982 (1998-12-01), Audia et al.
patent: 5869479 (1999-02-01), Kreutner et al.
patent: 6162818 (2000-12-01), Henry et al.
patent: 0 470 039 (1994-12-01), None
patent: 63-227573 (1988-09-01), None
patent: WO 98/06394 (1998-02-01), None
patent: WO 01/46181 (2001-06-01), None
patent: WO 02/32893 (2002-04-01), None
patent: 02/36589 (2002-05-01), None
patent: 02/072093 (2002-09-01), None
patent: WO 02/072570 (2002-09-01), None
McLeod et al. “Histamine H3 antagonists” CA 136:48247 (2001).
Terzioglu et al. Synthesis and structure-activity relationships . . . Bioorganic Med. Chem. Lett. vol. 14, p.5251-56 (2004).
Baker Bott “In print reach-through claims” Attorneys practice profiles news and events (2002).
Rizzo et al.,European Journal of Pharmacology, vol. 294 (1995) pp. 329-335.
G. Heinisch et al.,Monatshefte fur Chemie, vol. 104 (1973) pp. 1372-1382.
Obase et al.,J. Heterocyclic Chemistry, vol. 20 (1983) pp. 565-573.
U.S. Appl. No. 10/417,391 pp. 1-127.
U.S. Appl. No. 10/414,943 pp. 1-87.
Aslanian Robert G.
Berlin Michael Y.
Mangiaracina Pietro
McCormick Kevin D.
Mutahi Mwangi W.
Chang Celia
Magatti Anita W.
Schering Corporation
LandOfFree
Indole derivatives useful as histamine H3 antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indole derivatives useful as histamine H3 antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indole derivatives useful as histamine H3 antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3471128